We compared our results to previously reported metabolomics analyses conducted in plasma from FMR1 premutation with and without FXTAS patients and frozen brain tissue from a mouse model of FXTAS (Table 4). This evidence concerns the gene FMR1 and fragile X-associated tremor/ataxia syndrome.